Literature DB >> 11260529

Large melanocytic nevi in hereditary epidermolysis bullosa.

J W Bauer1, H Schaeppi, C Kaserer, B Hantich, H Hintner.   

Abstract

Large melanocytic nevi occurring in areas of former blistering in patients with hereditary epidermolysis bullosa (EB) pose a problem to the clinician with regard to prognosis and therapy because they may show clinical and histopathologic features strikingly resembling malignant melanoma. To investigate clinical and histologic criteria as well as the biologic behavior of these nevi, pigmented lesions of 12 patients (EB simplex, n = 1; junctional EB, n = 7; dystrophic EB, n = 4) of the Austrian EB registry were analyzed. Clinically, the nevi are up to palm sized, are initially very dark, and may exhibit stippled pigmentation and irregular borders that outline areas of former blisters. Over time they usually lose pigment, the surface gets papillomatous, and finally they acquire a shagreen-like appearance. Histopathologically, the nevi frequently exhibit a compound congenital or persisting nevus/pseudomelanoma pattern. Despite this combination of features, no malignant transformation of the nevi has been seen by us even after 20 years of prospective surveillance. Because nevi with these criteria do not fit in any of the known categories, we suggest the term EB nevi.

Entities:  

Mesh:

Year:  2001        PMID: 11260529     DOI: 10.1067/mjd.2001.112217

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  6 in total

1.  Surgical suturing-induced melanocytic nevi. A new type of eruptive melanocytic nevi?

Authors:  Alexander C Katoulis; Dimitrios Sgouros; Giuseppe Argenziano; Efstathios Rallis; Ioannis Panayiotides; Dimitrios Rigopoulos
Journal:  J Dermatol Case Rep       Date:  2016-11-30

2.  Collagen XVII is expressed in malignant but not in benign melanocytic tumors and it can mediate antibody induced melanoma apoptosis.

Authors:  T Krenacs; G Kiszner; E Stelkovics; P Balla; I Teleki; I Nemeth; E Varga; I Korom; T Barbai; V Plotar; J Timar; E Raso
Journal:  Histochem Cell Biol       Date:  2012-06-12       Impact factor: 4.304

3.  Epidermolysis bullosa nevi: report of a case and review of the literature.

Authors:  Laura Abdo Nalon de Queiroz Fuscaldi; Alice Mota Buçard; Carlos Daniel Quiroz Alvarez; Carlos Baptista Barcaui
Journal:  Case Rep Dermatol       Date:  2011-11-29

4.  Transcriptome and ultrastructural changes in dystrophic Epidermolysis bullosa resemble skin aging.

Authors:  Jenny S Breitenbach; Mark Rinnerthaler; Andrea Trost; Manuela Weber; Alfred Klausegger; Christina Gruber; Daniela Bruckner; Herbert A Reitsamer; Johann W Bauer; Michael Breitenbach
Journal:  Aging (Albany NY)       Date:  2015-06       Impact factor: 5.682

Review 5.  Bioengineered Efficacy Models of Skin Disease: Advances in the Last 10 Years.

Authors:  Diana Nicole Stanton; Gitali Ganguli-Indra; Arup Kumar Indra; Pankaj Karande
Journal:  Pharmaceutics       Date:  2022-01-28       Impact factor: 6.321

Review 6.  Pre-Cancerous Lesions in the Oral and Maxillofacial Region: A Literature Review with Special Focus on Etiopathogenesis.

Authors:  Soussan Irani
Journal:  Iran J Pathol       Date:  2016
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.